Murine infection with bioluminescent Leishmania infantum axenic amastigotes applied to drug discovery
Open Access
- 12 December 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-8
Abstract
Leishmaniasis is an important vector-borne neglected tropical disease caused by Leishmania parasites. Current anti-Leishmania chemotherapy is unsatisfactory, justifying the continued search for alternative treatment options. Herein, we demonstrate that luciferase-expressing Leishmania infantum axenic amastigotes, unlike promastigotes, are highly infectious to BALB/c mice and thus generate a robust bioluminescent signal in target organs, such as the liver and the spleen, as early as two weeks after infection. Treatment with the reference drugs amphotericin B and miltefosine was effective at reducing parasite burdens. This model allows the assessment of treatment efficacy using whole-mouse bioluminescence imaging without the need to wait several weeks for spleen infections to be detectable by this non-invasive method. In conclusion, we propose the use of this model in an initial approach to evaluate the treatment efficacy of promising chemical entities without having to sacrifice large numbers of animals or to wait several days for a readout.Keywords
This publication has 33 references indexed in Scilit:
- In-vivo monitoring of infectious diseases in living animals using bioluminescence imagingVirulence, 2017
- Leishmaniasis drug discovery: recent progress and challenges in assay developmentDrug Discovery Today, 2017
- In vivo imaging of pathogen homing to the host tissuesMethods, 2017
- Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing needNature Reviews Microbiology, 2017
- Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the hostParasitology International, 2017
- Neglected tropical diseases: progress towards addressing the chronic pandemicThe Lancet, 2017
- New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open ResourceScientific Reports, 2015
- Generation of Luciferase-Expressing Leishmania infantum chagasi and Assessment of Miltefosine Efficacy in Infected Hamsters through BioimagingPLOS Neglected Tropical Diseases, 2015
- High-Throughput Screening Platform for Natural Product–Based Drug Discovery Against 3 Neglected Tropical Diseases: Human African Trypanosomiasis, Leishmaniasis, and Chagas DiseaseSLAS Discovery, 2015
- THE ROLE OF pH AND TEMPERATURE IN THE DEVELOPMENT OF LEISHMANIA PARASITESAnnual Review of Microbiology, 1994